The Diagnostic Accuracy in Sepsis Act of 2025 would amend the Medicare hospital-acquired conditions framework to treat blood culture contamination as a hospital-acquired condition beginning with fiscal year 2026 discharges. The bill also directs the Secretary of Health and Human Services to establish a blood culture contamination measure for subsection (d) hospitals and specifies that the contamination rate should not exceed 1 percent for purposes of that measure.
In practical terms, the bill would add a new quality and payment-related metric to Medicare’s hospital-acquired condition program under section 1886(p) of the Social Security Act. Hospitals that exceed the contamination threshold could be affected in how they are identified as applicable hospitals under the Medicare program, which may influence reimbursement and quality reporting incentives. The bill is narrowly focused on diagnostic accuracy and sepsis-related blood culture practices rather than broader Medicare coverage changes.
The available context shows no recorded committee debate or votes, so there is no documented public sentiment from hearings or floor action. Based on the bill text and title, the measure appears intended to improve patient safety and diagnostic reliability by discouraging contaminated blood cultures, which can lead to misdiagnosis, unnecessary treatment, and delayed sepsis care.
Because there is no transcript or vote history, there are no identified points of contention in the provided materials. Potential areas of debate, if the bill advances, could include the feasibility of a 1 percent contamination benchmark, the administrative burden on hospitals, and whether a federal quality measure should apply uniformly across facilities with different patient populations and testing practices.
Impact
The bill would amend section 1886(p) of the Social Security Act, expanding the Medicare hospital-acquired conditions definition to include blood culture contamination for discharges in fiscal year 2026 and later. It would also require HHS to create a specific contamination measure for subsection (d) hospitals, with a stated benchmark that the contamination rate should not exceed 1 percent. This would affect Medicare-participating acute care hospitals by adding a new compliance and quality-performance standard tied to hospital-acquired condition determinations.
Sentiment
There is no committee transcript or vote record in the provided materials, so formal sentiment cannot be measured from legislative debate. The bill’s title and structure suggest a generally supportive patient-safety rationale, aimed at improving diagnostic accuracy in sepsis care and reducing avoidable contamination in blood cultures. No opposition is documented in the available context.
Contention
No explicit points of contention are recorded in the provided materials because there are no transcripts or votes. If debated, likely issues would include whether the 1 percent threshold is realistic, how contamination should be measured and risk-adjusted, the administrative burden on hospitals, and whether the policy could unintentionally penalize facilities serving more complex patient populations.